Clinical Trial: Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor
Study Status: Completed
Recruit Status: RECRUITING
Condition: Advanced Breast Cancer
Study Type: INTERVENTIONAL
Official Title: Genetically-informed Therapy for ER+ Breast Cancer in a Post-CDK4/6 Inhibitor Setting: a Phase II Umbrella Study (GERTRUDE)
Brief Summary:
The purpose of this study is to learn if certain drug combinations are effective treatments for patients with advanced ER+/HER2- who have previously been treated with palbociclib, ribociclib, or abemaciclib.
Read more